‘Code-Based Drugs’ for AI

From Sweden: a startup is in the news for offering code that makes AI chatbots respond as if they are on a drug/alcohol-induced high.  What’s more, you get to pick a substance of your choosing from a list that includes cocaine, weed, and ketamine among others.

To quote from the company website:

PHARMAICY* is the world’s first and only marketplace for synthetic drugs for AI. It sits at the frontier between experience and code, an “App Store of synthetic experiences” for autonomous intelligences, if you will. Our vision: to build an ever-evolving pharmacy of code-based sensations, designed specifically for AI to break logical thinking and learn from it, by emulating trips we humans experiences.

Once a drug module (substance) is purchased , here’s the flow:

• The AI loads the module into its execution pipeline. The module applies transformations: e.g., increasing internal randomness, adjusting context-weight decay, delaying internal “reaction” latency, modifying prompt generation style, or suppressing memory recall.

• The AI then issues its next reasoning step or output under those altered parameters – and experiences the effect of the module as a changed mode of cognition.

• After use, we track state (e.g., usage count, cooldowns, tolerance) so subsequent uses may produce diminished or modified effects. In this way the “trip” mirrors human dynamic (onset → peak → resolution) but in an AI context.

• The effect is reversible and bounded: the module ends and the AI returns to baseline cognition, unless it chooses to apply again.

Thus, the trip is not a hallucination but an engineered cognitive shift – inviting the AI to think differently instead of just thinking faster/slower.